Cargando…

Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis

OBJECTIVE: Changes in glucose metabolism occurring during counterregulation are, in part, mediated by increased plasma free fatty acids (FFAs), as a result of hypoglycemia-activated lipolysis. However, it is not known whether FFA plays a role in the development of posthypoglycemic insulin resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucidi, Paola, Rossetti, Paolo, Porcellati, Francesca, Pampanelli, Simone, Candeloro, Paola, Andreoli, Anna Marinelli, Perriello, Gabriele, Bolli, Geremia B., Fanelli, Carmine G.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874695/ https://www.ncbi.nlm.nih.gov/pubmed/20299466 http://dx.doi.org/10.2337/db09-0745

Ejemplares similares

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus
por: Porcellati, Francesca, et al.
Publicado: (2011)

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans
por: Rossetti, Paolo, et al.
Publicado: (2009)

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes
por: Lucidi, Paola, et al.
Publicado: (2012)

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study
por: Lucidi, Paola, et al.
Publicado: (2011)

Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials
por: Porcellati, Francesca, et al.
Publicado: (2017)

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People
por: Rossetti, Paolo, et al.
Publicado: (2008)

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2011)

Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes
por: Porcellati, Francesca, et al.
Publicado: (2013)

Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
por: Porcellati, Francesca, et al.
Publicado: (2021)

Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs
por: Werner, Ulrich, et al.
Publicado: (2020)

Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
por: Bolli, Geremia B., et al.
Publicado: (2022)

Hypoglycemia, Diabetes, and Cardiovascular Events
por: Desouza, Cyrus V., et al.
Publicado: (2010)

Comparable efficacy with similarly low risk of hypoglycaemia in patient‐ vs physician‐managed basal insulin initiation and titration in insulin‐naïve type 2 diabetic subjects: The Italian Titration Approach Study
por: Bonadonna, Riccardo C., et al.
Publicado: (2020)

Adipocyte lipolysis drives acute stress-induced insulin resistance
por: Raje, Vidisha, et al.
Publicado: (2020)

Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide–Donating Agent
por: Gresele, Paolo, et al.
Publicado: (2010)

RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women
por: Kilicarslan, Murat, et al.
Publicado: (2020)

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes
por: Bolli, G B, et al.
Publicado: (2011)

The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
por: Owens, David R., et al.
Publicado: (2020)

Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding
por: Shen, Yachen, et al.
Publicado: (2017)

Brain insulin signaling suppresses lipolysis in the absence of peripheral insulin receptors and requires the MAPK pathway
por: Metz, Matthäus, et al.
Publicado: (2023)

Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes
por: Groener, Jan Benedikt, et al.
Publicado: (2019)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
por: Armstrong, M J, et al.
Publicado: (2014)

Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance
por: Sidibeh, Cherno O., et al.
Publicado: (2016)

FRI020 Adipocyte Subpopulations Regulate Growth Hormone-induced Lipolysis And Insulin Resistance
por: Siyar, Sohana, et al.
Publicado: (2023)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population
por: Gómez, Ana M., et al.
Publicado: (2019)

Effect of Naloxon on Counter Insulin Hormone Secretion in Insulin-Induced Hypoglycemia
por: Ju, Yeong Shil, et al.
Publicado: (1987)

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
por: Su, Chih-Ting, et al.
Publicado: (2016)

Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling
por: Vestergaard, Esben Thyssen, et al.
Publicado: (2008)

Type B Insulin Resistance Syndrome: A Rare Cause of Hypoglycemia
por: Bhat, Salman Zahoor, et al.
Publicado: (2023)

Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue
por: Zhao, Jia, et al.
Publicado: (2020)

Insulin Detemir Versus Insulin Glargine in the Hospital: Do Hypoglycemia Rates Differ?
por: Crisher, Michelle A., et al.
Publicado: (2019)

Importance of Insulin Immunoassays in the Diagnosis of Factitious Hypoglycemia
por: Nalbantoğlu Elmas, Özlem, et al.
Publicado: (2014)

The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017)

Paliperidone Induced Hypoglycemia by Increasing Insulin Secretion
por: Omi, Tsubasa, et al.
Publicado: (2016)

Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans
por: Verboven, K., et al.
Publicado: (2018)

Ginsenoside Rg5 Inhibits Succinate-Associated Lipolysis in Adipose Tissue and Prevents Muscle Insulin Resistance
por: Xiao, Na, et al.
Publicado: (2017)

Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance
por: Wang, Lulu, et al.
Publicado: (2016)

Mass recovery following caloric restriction reverses lipolysis and proteolysis, but not gluconeogenesis, in insulin resistant OLETF rats
por: Cornejo, Manuel A., et al.
Publicado: (2021)

Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
por: Buscemi, Silvio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36a3e8vchrn5bbqmj5j9u6tj0t